Back
Marinus Pharmaceuticals Stock Price Chart
The #1 free indicator I've used for 30 years
The indicator is free... and the 23-page book I wrote for you is also free.
Sell
28
MRNS
Marinus Pharmaceuticals
Last Price:
1.20
Seasonality Move:
31.72%
7 Day Trial
ALL ACCESS PASS
$
7
A massive $1 Trillion AI superproject is underway
Click here to discover these key companies behind this $1 trillion Superproject- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing slight selling pressure.
Marinus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.31 | Sell |
| 20-day SMA: | 1.42 | Sell |
| 50-day SMA: | 1.41 | Sell |
| 200-day SMA: | 6.57 | Sell |
| 8-day EMA: | 1.3 | Sell |
| 20-day EMA: | 1.4 | Sell |
| 50-day EMA: | 2.3 | Sell |
| 200-day EMA: | 5.62 | Sell |
Marinus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 25.72 | Sell |
| Chaikin Money Flow: | -1752708 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.52) | Sell |
| Bollinger Bands (100): | (1.15 - 8.99) | Sell |
Marinus Pharmaceuticals Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Marinus Pharmaceuticals Stock
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 1.17 while MRNS 8-day simple moving average is 1.31, which is a Sell signal.
- The stock price of MRNS is 1.17 while Marinus Pharmaceuticals 20-day SMA is 1.42, which makes it a Sell.
- Marinus Pharmaceuticals 50-day simple moving average is 1.41 while MRNS share price is 1.17, making it a Sell technically.
- MRNS stock price is 1.17 and Marinus Pharmaceuticals 200-day simple moving average is 6.57, creating a Sell signal.
MRNS Technical Analysis vs Fundamental Analysis
Sell
28
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy or a Sell?
-
Marinus Pharmaceuticals stock is rated a Sell
The current Marinus Pharmaceuticals [MRNS] share price is $1.17. The Score for MRNS is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Marinus Pharmaceuticals Stock Info
Market Cap:
64.27M
Price in USD:
1.17
Share Volume:
7.89M
Marinus Pharmaceuticals 52-Week Range
52-Week High:
11.26
52-Week Low:
1.10
Sell
28
Marinus Pharmaceuticals (MRNS)
is a Sell
Marinus Pharmaceuticals Share Price Forecast
-
What is the Marinus Pharmaceuticals stock price today?
The Marinus Pharmaceuticals stock price is 1.17 USD today. -
Will MRNS stock go up or go down?
Marinus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Marinus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Marinus Pharmaceuticals is overvalued.
Is Marinus Pharmaceuticals Stock a Buy?
- Marinus Pharmaceuticals share price is 1.17 while MRNS 8-day exponential moving average is 1.30, which is a Sell signal.
- The stock price of MRNS is 1.17 while Marinus Pharmaceuticals 20-day EMA is 1.40, which makes it a Sell.
- Marinus Pharmaceuticals 50-day exponential moving average is 2.30 while MRNS share price is 1.17, making it a Sell technically.
- MRNS stock price is 1.17 and Marinus Pharmaceuticals 200-day simple moving average is 5.62, creating a Sell signal.
Fundamental Analysis of Marinus Pharmaceuticals
Is Marinus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.24 per share, an increase this year of $0.58 per share, and an increase next year of $0.88 per share.
Technical Analysis of Marinus Pharmaceuticals
Should I short Marinus Pharmaceuticals stock?
- MRNS Moving Average Covergence Divergence (MACD) indicator is -0.17, suggesting Marinus Pharmaceuticals is a Sell
- Marinus Pharmaceuticals Relative Strength Index (RSI) is 25.72, which suggest Marinus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Marinus Pharmaceuticals is (1.32 - 1.52), which suggest Marinus Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Marinus Pharmaceuticals is (1.15 - 8.99), which suggest Marinus Pharmaceuticals is a Sell
* Marinus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.